4,104
Views
6
CrossRef citations to date
0
Altmetric
Articles

The Taiwan Tobacco and Liquor Corporation: To ‘join the ranks of global companies’

, &
Pages 335-350 | Received 02 Jun 2016, Accepted 21 Nov 2016, Published online: 31 Jan 2017
 

ABSTRACT

Until the late 1990s, the Taiwan Tobacco and Liquor Corporation (TTL) focused almost exclusively on serving the domestic market as a highly protected monopoly. This paper describes how the company has adopted a more outward looking strategy since 2000, with ambitions to become a regional, and eventually global, business by 2021. Drawing on company documents and industry sources, the paper argues that this shift in strategy was a direct reaction to the decline in domestic market share following liberalisation of the Taiwanese tobacco market and adoption of tougher domestic tobacco control measures. Market opening occurred as a result of pressure from the U.S. Trade Representative in the 1980s, as well as World Trade Organization membership in 2002. It is argued that TTL’s efforts to globalise operations have been limited by bureaucratic company management and structures, and ongoing political tension between Taiwan and China. However, the relative success of TTL’s alcohol branch, and potential détente as the Taiwanese government reaches out to improve relations with China, may provide TTL with new opportunities to achieve its goal of becoming a regional player with global ambitions. This article is part of the special issue ‘The Emergence of Asian Tobacco Companies: Implications for Global Health Governance.’

Acknowledgements

The authors are solely responsible for the contents of this paper.

Disclosure statement

No potential conflict of interest was reported by the authors.

Notes

1. The current name of the company, TTL, was adopted in 2002. To avoid confusion, we refer to the company throughout the paper as TTL including the period prior to 2002 when the company was differently named (i.e. Monopoly Bureau of the Taiwan Governor’s Office, Taiwan Tobacco and Wine Monopoly Bureau).

Additional information

Funding

This work is supported by the National Cancer Institute, US National Institutes of Health [grant number R01-CA091021].